Skip to content

The effect and safety of endoscopic treatment in colorectal precancerous lesion and early carcinoma

The effect and safety of endoscopic treatment in colorectal precancerous lesion and early carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17013336
Enrollment
Unknown
Registered
2017-11-10
Start date
2017-12-01
Completion date
Unknown
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal precancerous lesion and early carcinoma

Interventions

Case series:ESD

Sponsors

Beijing Friendship Hospital, CCMU, Beijing, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Lesions unable to be resect by EMR: LST-NG, particularly LST-NG (PD); Pit pattern Vi; 2. Carcinoma with shallow T1 (SM) invasion; 3. Large depressed-type tumors or large protruded-type lesions suspected to be carcinoma; 4. Mucosal tumors with submucosal fibrosis sporadic localized tumors in conditions of chronic inflammation such as ulcerative colitis; 5. Local residual or recurrent early carcinomas after endoscopic resection.

Exclusion criteria

Exclusion criteria: 1. Combined with severe diseases of cardioncerebral vascular system, respiratiory system, renal and blood; 2. Combined with severe mental diseases; 3. With contrainications in colonscopy; 4. The patient who were thought couldn't complete the trial.

Design outcomes

Primary

MeasureTime frame
en bloc resection rate;Complication incidence;Five-year recurrence;Five-year survival rate;

Secondary

MeasureTime frame
Risk factors of complications;Five-year survival of different endoscopic methods;

Countries

China

Contacts

Public ContactJiao Yue

Gastroenterology Department, Beijing Friendship Hospital

13811679359@163.com+86 13811679359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026